|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
PhaSeal has been the only clinically proven closed-system drug transfer device for the safe handling of hazardous drugs.
ITNS Congratulates Mark Lockwood, MSN RN CCRC
Congratulations to Mark Lockwood for his presentation on Renal Transplantation and the Digital Divide: Does Information and Communication Technology Represent a Barrier or a Bridge to Transplantation for African Americans? at the Sigma Theta Tau International, Honors Society of Nursing, 42nd Biennial Convention in Indianapolis, Indiana, USA — 16-20 November 2013.
The call for abstracts for the 23rd Annual ITNS Symposium is now open!|
Submit your abstract before the 15 January 2014 deadline.
Latest technology offers promise for patients awaiting kidney transplants
By Joy Burgess
Many patients today spend years waiting for the live-saving transplant they require. Even with live organ donors stepping in to offer organs for loved ones, there still are not enough organs for patients awaiting transplantation. This lack of organs has led scientists to search for ways to grow or manufacture transplantable organs to fit this need. From biokidneys to 3-D printing, scientists have taken several approaches recently to solve this problem.
Europe aims to clamp down on human organ trade
Europe's multi-national human rights organization, the Council of Europe, is discussing a draft convention banning the trafficking of human organs. Still, the criminal practice could take years to stop around the world.
Like ITNS on Facebook! Visit the ITNS Facebook page for the latest ITNS and transplant news.
US: Federal regulation could redefine the word 'organ,' jeopardize bone marrow donations
Three of Doreen Flynn's children were born with a rare, debilitating blood disease. Desperate to save her children’s lives, she challenged a decades-old, outdated ban on compensating bone marrow donors. She won in federal court.
But now a new rule proposed by the federal Department of Health and Human Services would undo this landmark decision and jeopardize this life-saving treatment.
Robyn Urback: What Canada can learn from Israel on organ donation
The National Post
When Canadians must resort to online ads to find themselves human organs for transplant, we might have a bit of a problem on our hands. Yet a Nova Scotia man took to online classifieds this month in a desperate attempt to find himself a new kidney. Ken Wilkie, who has polycystic kidney disease, posted an ad on Kijiji on November 7 under the title "Boost Your Karma."
Organ donation in Nova Scotia is restricted by conditions under the Human Organ and Tissue Donation Act, which states that there can be no economic incentive to the living organ donor. In other words, you can't buy a kidney. Wilkie found a loophole in his promise of good "karma," however, since karma can't be used to finance a loan. The implicit idea is that if you do a good deed, a good deed will later come to you.
HCC-based transplants straining donor pool
The increase in the number of hepatocellular carcinoma patients in the U.S. being wait-listed for transplant is leading to a greater incidence of wait-listing for all individuals with hepatitis C, a speaker said. "The demand for liver transplantation for hepatocellular carcinoma is likely going to continue to rise and further strain our already limited donor pool," Dr. Jennifer A. Flemming, FRCP(C), MAS, of the University of California at San Francisco, said at The Liver Meeting. "This could influence HCC listing policy over the next decade and may push the transplant community to consider nontransplant alternatives [for HCC patients]."
Missed last week's issue? See which articles your colleagues read most.
Study shows how thymoglobulin reduces rejection risk in kidney transplant
Treatment with thymoglobulin has a clear advantage for patients after kidney transplant because it helps reduce the risk of organ rejection.
Antibody induction therapy is a way of reducing organ rejection after a transplant. It helps to prepare the immune system for the introduction of a new organ. The two most common antibodies used are thymoglobulin and basiliximab. In a new trial carried out by researchers at Washington University School of Medicine the two antibodies are compared for their ability to reduce rejection of a new kidney.
Toddler set for bone marrow transplant after appeal inspires ten-fold increase in Asian donors
The Daily Mirror
A toddler is set for a bone marrow transplant after he inspired a 10-fold increase in the number of Asian donors.
Doctors told Gaurav Bains's family he could become seriously ill if he did not have a transplant by Christmas as he was likely to develop an aggressive form of childhood leukaemia.
But thanks to an overwhelming response, the two-year-old has been found a match and will undergo a potentially life-saving transplant next month.
Transplant: How research is improving lives now
The transplant surgery may be the first big hurdle patients have to get through, but it's certainly not the last. For all transplanted organs, the definitive way to check for rejection is with an invasive biopsy. This is a catheter procedure done under general anesthetic for pediatric patients, minimal or no anesthetic for adults. During the procedure, small samples of organ tissue are taken with tiny tweezers. Those samples are examined by a pathologist for signs of rejection. The results can potentially be inaccurate because the samples may come back negative even if there is rejection in other parts of the organ. Research at St. Paul's Hospital and the PROOF Centre is about to change that, starting with cardiac patients.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063